Study of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer; Cypress 2

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleStudy of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer; Cypress 2
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsMissak Haigentz